|
Calcium in PDB 8we8: Human L-Type Voltage-Gated Calcium Channel CAV1.2 in the Presence of Calciseptine, Amlodipine and Pinaverium at 2.9 Angstrom ResolutionOther elements in 8we8:
The structure of Human L-Type Voltage-Gated Calcium Channel CAV1.2 in the Presence of Calciseptine, Amlodipine and Pinaverium at 2.9 Angstrom Resolution also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Human L-Type Voltage-Gated Calcium Channel CAV1.2 in the Presence of Calciseptine, Amlodipine and Pinaverium at 2.9 Angstrom Resolution
(pdb code 8we8). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 2 binding sites of Calcium where determined in the Human L-Type Voltage-Gated Calcium Channel CAV1.2 in the Presence of Calciseptine, Amlodipine and Pinaverium at 2.9 Angstrom Resolution, PDB code: 8we8: Jump to Calcium binding site number: 1; 2; Calcium binding site 1 out of 2 in 8we8Go back to![]() ![]()
Calcium binding site 1 out
of 2 in the Human L-Type Voltage-Gated Calcium Channel CAV1.2 in the Presence of Calciseptine, Amlodipine and Pinaverium at 2.9 Angstrom Resolution
![]() Mono view ![]() Stereo pair view
Calcium binding site 2 out of 2 in 8we8Go back to![]() ![]()
Calcium binding site 2 out
of 2 in the Human L-Type Voltage-Gated Calcium Channel CAV1.2 in the Presence of Calciseptine, Amlodipine and Pinaverium at 2.9 Angstrom Resolution
![]() Mono view ![]() Stereo pair view
Reference:
S.Gao,
X.Yao,
J.Chen,
G.Huang,
X.Fan,
L.Xue,
Z.Li,
T.Wu,
Y.Zheng,
J.Huang,
X.Jin,
Y.Wang,
Z.Wang,
Y.Yu,
L.Liu,
X.Pan,
C.Song,
N.Yan.
Structural Basis For Human Ca V 1.2 Inhibition By Multiple Drugs and the Neurotoxin Calciseptine. Cell V. 186 5363 2023.
Page generated: Fri Jul 19 12:37:54 2024
ISSN: ISSN 1097-4172 PubMed: 37972591 DOI: 10.1016/J.CELL.2023.10.007 |
Last articlesZn in 9J0NZn in 9J0O Zn in 9J0P Zn in 9FJX Zn in 9EKB Zn in 9C0F Zn in 9CAH Zn in 9CH0 Zn in 9CH3 Zn in 9CH1 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |